In Vivo Imaging for the Detection and Quantitation of Transplanted Stem/Progenitor Cells in Nonhuman Primates

In Vivo Imaging for the Detection and Quantitation of Transplanted Stem/Progenitor Cells in Nonhuman Primates

Funding Type: 
Tools and Technologies I
Grant Number: 
RT1-01019
Award Value: 
$799,350
Stem Cell Use: 
Adult Stem Cell
Status: 
Closed
Public Abstract: 
Statement of Benefit to California: 
Progress Report: 

Year 1

Stem cells hold great potential for treating a variety of human diseases, but more information is needed on how they will function once administered to patients for regenerative medicine purposes. Our studies are focused on addressing new ways to optimize the use of positron emission tomography (PET), an imaging technology used in the human clinical setting, to monitor stem and progenitor cells post-transplantation. In our studies we have accomplished our stated milestones and optimized PET imaging techniques by addressing the sensitivity of the scanner and ways to improve the detection of small quantities of transplanted cells. We have also carefully identified methods for safely placing imaging labels on the cells without altering the proliferative and growth potential of the cells under investigation. We are now poised to use our model systems to test how these improvements enhance our established imaging protocols.

Year 2

Imaging methods to monitor stem and progenitor cells post-transplant are needed to assess engrafted cells once injected into the body and over time. These studies are addressing the refinements needed in PET imaging equipment to effectively locate the cells, and ways to safely label the cells without altering their capabilities and functions in a preclinical setting.

Year 3

Noninvasive imaging systems include a wide range of technologies that make use of different contrast mechanisms to provide images that can reflect anatomy, physiology, metabolism, and more specifically interactions with proteins, gene expression, or to track therapeutic molecules and transplanted stem and progenitor cells. While in vivo imaging technologies are clearly essential for the development of new stem cell therapies for humans, imaging techniques with sufficient sensitivity to detect small quantities of cells are needed to monitor and evaluate safety and efficiency of new stem cell therapies for a spectrum of human diseases. Nuclear medicine techniques, especially positron emission tomography (PET), have much higher sensitivity than other imaging modalities and can provide 3D quantitative images. Outcomes using PET imaging can also be translated from animal models to humans. These studies focused on two overriding objectives: to assess current PET imaging systems with the goal of understanding and improving detection and quantification of stem cells transplanted in vivo; and to develop methods to radiolabel stem and progenitor cells for transplant and short-term tracking in vivo with PET. These studies have shown that some commercial PET scanners are not as sensitive as others for imaging low-activity sources produced by labeled cells because of inherent background noise that confounds PET imaging. In addition, new methods for labeling cells in vitro and in vivo have been developed that will aid in identifying engrafted stem/progenitor cells using PET post-transplantation.

© 2013 California Institute for Regenerative Medicine